Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy

Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy

Urothelial bladder cancer (UBC) is heterogeneous at the clinical, pathological, and genetic levels. Tumor invasiveness (T) and grade (G) are the main factors associated with outcome and determine patient management (1). A discovery exome sequencing screen (n=17), followed by a prevalence screen (n=6...

Full description

Bibliographic Details
Main Authors: Balbás-Martínez, Cristina, Sagrera, Ana, Carrillo-de-Santa-Pau, Enrique, Earl, Julie, Márquez, Mirari, Vazquez, Miguel, Lapi, Eleonora, Castro-Giner, Francesc, Beltran, Sergi, Bayés, Mònica, Carrato, Alfredo, Cigudosa, Juan C., Domínguez, Orlando, Gut, Marta, Herranz, Jesús, Juanpere, Núria, Kogevinas, Manolis, Langa, Xavier, López-Knowles, Elena, Lorente, José A., Lloreta, Josep, Pisano, David G., Richart, Laia, Rico, Daniel, Salgado, Rocío N., Tardón, Adonina, Chanock, Stephen, Heath, Simon, Valencia, Alfonso, Losada, Ana, Gut, Ivo, Malats, Núria, Real, Francisco X.
Format: Online
Language:English
Published: 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840052/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840052/

Similar Items